Risk and Management of Patients with Cancer and Heart Disease

Autor: Loreena Hill, Bruno Delgado, Ekaterini Lambrinou, Tara Mannion, Mark Harbinson, Claire McCune
Jazyk: angličtina
Rok vydání: 2023
Předmět:
Zdroj: Cardiology and Therapy, Vol 12, Iss 2, Pp 227-241 (2023)
Druh dokumentu: article
ISSN: 2193-8261
2193-6544
DOI: 10.1007/s40119-023-00305-w
Popis: Abstract Cancer and cardiovascular disease are two of the leading causes of global mortality and morbidity. Medical research has generated powerful lifesaving treatments for patients with cancer; however, such treatments may sometimes be at the expense of the patient’s myocardium, leading to heart failure. Anti-cancer drugs, including anthracyclines, can result in deleterious cardiac effects, significantly impacting patients’ functional capacity, mental well-being, and quality of life. Recognizing this, recent international guidelines and expert papers published recommendations on risk stratification and care delivery, including that of cardio-oncology services. This review will summarize key evidence with a focus on anthracycline therapy, providing clinical guidance for the non-oncology professional caring for a patient with cancer and heart failure.
Databáze: Directory of Open Access Journals
Nepřihlášeným uživatelům se plný text nezobrazuje